Skip to search formSkip to main contentSkip to account menu

c-Met/VEGFR-2 Kinase Inhibitor E7050

Known as: E7050 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

golvatinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Cancer Therapy : Preclinical Met Kinase Inhibitor E 7050 Reverses Three Different MechanismsofHepatocyteGrowth Factor – Induced Tyrosine Kinase Inhibitor Resistance in EGFR Mutant Lung Cancer
Purpose:Hepatocyte growth factor (HGF) induces resistance to reversible and irreversible epidermal growth factor receptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)